Lexicon Pharmaceuticals (stock symbol: LXRX) Logo in transparent PNG and SVG formats

Lexicon Pharmaceuticals Logo large

Lexicon Pharmaceuticals Logo icon format

Lexicon Pharmaceuticals Logo large for dark backgrounds

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

  • Website domain: lexpharma.com
  • Employees: 87
  • Marketcap: $0.46 Billion USD

Page last updated on:

August 6th, 2022